 Hyperparathyroidism, Secondary
"Hyperparathyroidism, Secondary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY.
| Descriptor ID |
D006962
|
| MeSH Number(s) |
C19.642.355.480
|
| Concept/Terms |
Hyperparathyroidism, Secondary- Hyperparathyroidism, Secondary
- Secondary Hyperparathyroidism
- Hyperparathyroidisms, Secondary
- Secondary Hyperparathyroidisms
|
Below are MeSH descriptors whose meaning is more general than "Hyperparathyroidism, Secondary".
Below are MeSH descriptors whose meaning is more specific than "Hyperparathyroidism, Secondary".
This graph shows the total number of publications written about "Hyperparathyroidism, Secondary" by people in this website by year, and whether "Hyperparathyroidism, Secondary" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 | | 2006 | 1 | 0 | 1 | | 2008 | 1 | 0 | 1 | | 2009 | 1 | 0 | 1 | | 2011 | 1 | 0 | 1 | | 2012 | 0 | 1 | 1 | | 2018 | 1 | 0 | 1 | | 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hyperparathyroidism, Secondary" by people in Profiles.
-
Stephens JM, Fox KM, Desai P, Cheng S, Goodman WG, Kendrick JB. Calcimimetic use in US hemodialysis facilities in first 2?years after the launch of etelcalcetide: A descriptive analysis of real-world clinical practice and outcomes. Hemodial Int. 2022 04; 26(2):243-254.
-
Jovanovich A, Kendrick J. Personalized Management of Bone and Mineral Disorders and Precision Medicine in End-Stage Kidney Disease. Semin Nephrol. 2018 07; 38(4):397-409.
-
Belozeroff V, Lee A, Tseng S, Chiroli S, Campbell JD. Cost per responder analysis in patients with secondary hyperparathyroidism on dialysis treated with cinacalcet. J Med Econ. 2013 Sep; 16(9):1154-62.
-
Ma NS, Gordon CM. The truth about vitamin D and adolescent skeletal health. Adolesc Med State Art Rev. 2012 Dec; 23(3):457-70.
-
Ginde AA, Wolfe P, Camargo CA, Schwartz RS. Defining vitamin D status by secondary hyperparathyroidism in the U.S. population. J Endocrinol Invest. 2012 Jan; 35(1):42-8.
-
Kooienga L, Fried L, Scragg R, Kendrick J, Smits G, Chonchol M. The effect of combined calcium and vitamin D3 supplementation on serum intact parathyroid hormone in moderate CKD. Am J Kidney Dis. 2009 Mar; 53(3):408-16.
-
Chonchol M, Locatelli F, Abboud HE, Charytan C, de Francisco AL, Jolly S, Kaplan M, Roger SD, Sarkar S, Albizem MB, Mix TC, Kubo Y, Block GA. A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis. Am J Kidney Dis. 2009 Feb; 53(2):197-207.
-
Spiegel DM, Casey L, Bell S, Parker M, Chonchol M. Achieving targets for bone and mineral metabolism: the impact of cinacalcet HCl in clinical practice. Hemodial Int. 2006 Oct; 10 Suppl 2:S24-7.
-
Charytan C, Coburn JW, Chonchol M, Herman J, Lien YH, Liu W, Klassen PS, McCary LC, Pichette V. Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis. Am J Kidney Dis. 2005 Jul; 46(1):58-67.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|